Human T-Cell Lymphotropic Virus Antibody Screening: Data Survey on 33,603 German Blood Donors Correlated to Confirmatory Tests

Vox Sanguinis ◽  
1985 ◽  
Vol 49 (5) ◽  
pp. 327-330
Author(s):  
P. Kühnl ◽  
S. Seidl ◽  
R. Kurth ◽  
J. Löwer ◽  
H.-D. Brede ◽  
...  
Vox Sanguinis ◽  
1985 ◽  
Vol 49 (5) ◽  
pp. 327-330 ◽  
Author(s):  
P. Kühnl ◽  
S. Seidl ◽  
R. Kurth ◽  
J. Lower ◽  
H.-D. Brede ◽  
...  

Transfusion ◽  
2014 ◽  
Vol 55 (4) ◽  
pp. 880-889 ◽  
Author(s):  
Rika A. Furuta ◽  
Guangyong Ma ◽  
Masao Matsuoka ◽  
Satoshi Otani ◽  
Harumichi Matsukura ◽  
...  

2010 ◽  
Vol 43 (6) ◽  
pp. 615-619 ◽  
Author(s):  
Maria Regina Dias-Bastos ◽  
Cláudia Di Lorenzo Oliveira ◽  
Anna Bárbara de Freitas Carneiro-Proietti

INTRODUCTION: Human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) are endemic in Brazil and are screened for in transfusion services since 1993. This study evaluated the evolution of the prevalence of HTLV-1 and 2 in blood donors of the Hemominas Foundation from 1993 to 2007, and its geographical distribution in State of Minas Gerais, Brazil. METHODS: The Hemominas Foundation is a centralized blood center in Minas Gerais, Brazil. The sources of data were the Hemominas Foundation Technical Bulletin and files from the centralized serological laboratory. Donors were tested in the period using enzyme linked immuno sorbent assays (ELISA), followed by Western blot, when repeatedly reactive. The data were analyzed by EPIINFO 6.2 and TABWIN 3.5 softwares. RESULTS: The average seroprevalence in the period 1993-2007 was 0.1%. A steady decline occurred from 0.4% in 1993 to below 0.1% in 2002 and later, with a transient peak of 0.5% in 1994. HTLV reactivity distribution was asymmetrical in the state, with regions of higher prevalence, interspersed with low prevalence areas. Comparison of positive and negative donors verified that increasing age was proportional to virus positivity. Odds ratio for age ranged from 1.43 (30 to 39 years-old) to 3.09 (50 to 65 years-old). Women had a greater chance of being positive (OR-1.64), as previously described. CONCLUSIONS: Possible explanations for HTLV-1/2 prevalence decline are the exclusion of positive donors from the donor pool, an increase in repeat donors and ELISA test improvement, with reduction in the number of false positive results.


2020 ◽  
Vol 11 ◽  
Author(s):  
Kazuo Itabashi ◽  
Tokuo Miyazawa ◽  
Akihiko Sekizawa ◽  
Akifumi Tokita ◽  
Shigeru Saito ◽  
...  

2000 ◽  
Vol 95 (5) ◽  
pp. 711-712 ◽  
Author(s):  
Pedro P Chieffi ◽  
Carlos S Chiattone ◽  
Elder N Feltrim ◽  
Rita CS Alves ◽  
Maria A Paschoalotti

2009 ◽  
Vol 65 (1) ◽  
pp. 38-40 ◽  
Author(s):  
CN Chaudhari ◽  
T Shah ◽  
RN Misra

Transfusion ◽  
2020 ◽  
Vol 60 (7) ◽  
pp. 1483-1491
Author(s):  
Jill‐Léa Ramassamy ◽  
Olivier Cassar ◽  
Manoushka Toumbiri ◽  
Abdoulaye Diané ◽  
Antony Idam Mamimandjiami ◽  
...  

2015 ◽  
pp. 31 ◽  
Author(s):  
Robinson Onoh ◽  
Augustine Okoye ◽  
Godswill Obed Ibegbulam ◽  
Ngozi Immaculata Ugwu ◽  
Chukwudi Siemon Anigbo ◽  
...  

1997 ◽  
Vol 57 (2) ◽  
pp. 142-148 ◽  
Author(s):  
Aluisio A. C. Segurado ◽  
Claudio S. Pannuti ◽  
Renu B. Lal ◽  
Laura M. Sumita ◽  
Ceila M. S. Malaque

Sign in / Sign up

Export Citation Format

Share Document